Skip to content

Clinical trials

Phase 4 Generalized Anxiety Disorder trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Generalized Anxiety Disorder Phase: Phase 4 Country / region: United States Clear all

28 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20031
20043
20057
20064
20071
20084
20103
20151
20181
20191
20201

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed24
Terminated3
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Massachusetts General Hospital5
University of Pennsylvania3
University of South Florida2
AbbVie1
Beth Israel Medical Center1
Creighton University1
Eli Lilly and Company1
Georgetown University1
Medical University of South Carolina1
Nathan Kline Institute for Psychiatric Research1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Generalized Anxiety Disorder28
Anxiety Disorders22
Panic Disorder9
Bipolar Disorder4
Major Depressive Disorder3
Phobia, Social3
Alcoholism2
Stress Disorders, Post-Traumatic2
Agoraphobia1
Cardiovascular Diseases1

Trials

Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.